#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14218	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2050	687.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1695	1695	T	772	T,C	710,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14218	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2050	687.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1429	1429	C	811	C	759	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14218	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2050	687.5	0	HET	.	.	.	A800G	.	800	800	A	1045	1045	A	898	A,G	615,232	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14218	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2050	687.5	0	HET	.	.	.	C481T	.	481	481	C	726	726	C	848	C,T	603,191	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3640	715.1	0	.	n	.	0	G1337A	SNP	1337	1337	G	1600	1600	A	836	A,G	772,3	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3640	715.1	0	.	n	.	0	T1971C	SNP	1971	1971	T	2234	2234	C	799	C	740	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3640	715.1	1	SNP	n	A2045G	0	.	.	2045	2045	A	2308	2308	A	828	A	789	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26138	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3640	715.1	1	SNP	n	C2597T	0	.	.	2597	2597	C	2860	2860	C	771	C	714	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2042	folP	855	855	100.0	folP.l15.c4.ctg.1	1499	135.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1044	1046	AGC	239;242;242	A;G;C	219;223;222	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5640	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3339	168.2	1	SNP	p	S91F	1	.	.	271	273	TTC	522	524	TTC	211;210;210	T;T;C,T,A	194;190;188,1,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5640	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3339	168.2	1	SNP	p	D95G	1	.	.	283	285	GGC	534	536	GGC	207;203;203	G;G;C	193;190;191	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5640	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3339	168.2	1	SNP	p	G95N	0	.	.	283	285	GGC	534	536	GGC	207;203;203	G;G;C	193;190;191	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1652	mtrR	633	633	100.0	mtrR.l6.c30.ctg.1	1272	128.9	1	SNP	p	G45D	0	.	.	133	135	GGC	424	426	GGC	189;190;189	G;G;C	176;176;175	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	788	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	904	86.2	0	.	n	.	0	A197.	DEL	197	197	A	518	518	A	196	A	178	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2913	168.2	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1502	1504	GTC	187;187;188	G;T;C	180;177;182	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2913	168.2	1	SNP	p	D86N	0	.	.	256	258	GAC	608	610	GAC	211;206;204	G;A;C	198;192;192	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2913	168.2	1	SNP	p	R87W	0	.	.	259	261	CGT	611	613	CGT	206;205;206	C;G;T	196;191;192	parC.WHO_V_00204c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2913	168.2	1	SNP	p	S87R	1	.	.	259	261	CGT	611	613	CGT	206;205;206	C;G;T	196;191;192	parC.WHO_V_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2913	168.2	1	SNP	p	R87I	0	.	.	259	261	CGT	611	613	CGT	206;205;206	C;G;T	196;191;192	parC.WHO_V_00204c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	4918	parC	2304	2304	99.87	parC.l15.c4.ctg.1	2913	168.2	1	SNP	p	S88P	0	.	.	262	264	TCC	614	616	TCC	205;208;206	T;C;C	194;193;193	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4574	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2570	177.1	0	.	p	.	0	R340C	NONSYN	1018	1020	CGC	1295	1297	TGC	206;207;207	T,C;G;C	194,1;197;196	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	4574	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2570	177.1	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1505	1507	GGC	230;229;230	G;G;C	217;212;210	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	A311V	0	.	.	931	933	GCA	1291	1293	GCA	229;230;229	G;C;A	217;214;219	penA.12.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	I312M	0	.	.	934	936	ATC	1294	1296	ATC	232;231;234	A;T;C	219;218;220	penA.12.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	V316T	0	.	.	946	948	GTG	1306	1308	GTG	228;226;225	G;T,G;G,C	212;209,1;207,1	penA.12.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	V316P	0	.	.	946	948	GTG	1306	1308	GTG	228;226;225	G;T,G;G,C	212;209,1;207,1	penA.12.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1810	1812	ACC	185;186;187	A;C;C	164;168;171	penA.12.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1864	1866	GCG	191;188;184	G;C;G	173;156;160	penA.12.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1864	1866	GCG	191;188;184	G;C;G	173;156;160	penA.12.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1987	1989	GGC	186;187;186	G;G;C	174;174;174	penA.12.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1996	1998	GGC	183;183;181	G;G;C	169;170;168	penA.12.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.12.001	penA.12.001	1	1	27	3920	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2571	152.3	1	SNP	p	P552S	1	.	.	1654	1656	TCG	2014	2016	TCG	183;185;182	T,G;C,T;G,C	124,8;146,1;154,1	penA.12.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5842	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3111	187.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1561	1563	CCG	212;214;211	C;C;G	186;195;190	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2348	porA	1146	1146	99.56	porA.l15.c4.ctg.1	1667	139.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	508	508	C	165	C	155	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	623	24.7	0	.	p	.	0	M18T	NONSYN	52	54	ATG	504	506	ACG	83;83;84	A;C;G	75;75;75	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	623	24.7	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	546	548	CAA	45;39;38	C;A;A	42;37;37	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	112	91.96	porB1a.l15.c30.ctg.1	623	24.7	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	552	554	TAC	25;24;22	T;A;C	25;24;22	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	V258L	NONSYN	772	774	GTA	102	104	TTA	48;49;49	T;T;A	46;47;46	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	147	149	CAT	58;58;56	C;A;T	53;52;52	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	D274S	NONSYN	820	822	GAT	150	152	AGT	57;58;57	A;G;T	52;53;51	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	159	161	TAC	57;57;57	T;A;C	53;52;54	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	R307A	NONSYN	919	921	AGA	249	251	GCA	17;17;16	G;C;A	17;17;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	T311A	NONSYN	931	933	ACA	261	263	GCA	16;16;16	G;C;A	16;16;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	E312D	NONSYN	934	936	GAA	264	266	GAC	15;14;14	G;A;C	15;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	F314I	NONSYN	940	942	TTC	270	272	ATC	13;12;12	A;T;C	13;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	A316S	NONSYN	946	948	GCG	276	278	TCG	12;12;12	T;C;G	11;11;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	V318A	NONSYN	952	954	GTC	282	284	GCC	13;13;13	G;C;C	12;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	G319S	NONSYN	955	957	GGC	285	287	AGC	11;11;11	A;G;C	11;10;11	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	G320A	NONSYN	958	960	GGT	288	290	GCC	10;10;10	G;C;C	9;10;9	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	324	porB1a	984	271	91.51	porB1a.l15.c30.ctg.2	429	28.0	0	.	p	.	0	G322V	NONSYN	964	966	GGT	294	296	GTT	10;10;10	G;T;T	9;9;9	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	0	.	p	.	0	N38E	NONSYN	112	114	AAT	497	499	GAA	240;236;236	G;A;A	219;217;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	0	.	p	.	0	N134D	NONSYN	400	402	AAT	785	787	GAT	222;222;226	G;A;T	204;206;211	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	0	.	p	.	0	P175S	NONSYN	523	525	CCA	908	910	TCA	233;235;234	T;C;A	213;213;215	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1037	1039	GTC	250;252;253	G;T;C	227;228;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	0	.	p	.	0	P219H	NONSYN	655	657	CCT	1040	1042	CAC	254;255;255	C;A;C	229;232;234	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1367	1369	GCA	234;231;232	G;C;A	214;212;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	1	SNP	p	G120K	1	.	.	358	360	AAG	743	745	AAG	208;209;213	A;A;G	192;191;194	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	1	SNP	p	D121N	0	.	.	361	363	GAC	746	748	GAC	213;213;212	G;A;C	194;194;193	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2776	porB1b	1047	1047	99.24	porB1b.l15.c17.ctg.1	1568	175.5	1	SNP	p	A121D	1	.	.	361	363	GAC	746	748	GAC	213;213;212	G;A;C	194;194;193	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9676	rpoB	4179	4179	100.0	rpoB.l15.c17.ctg.1	4981	193.7	1	SNP	p	H553N	1	.	.	1657	1659	AAT	2121	2123	AAT	235;238;235	A;A;T	226;227;224	rpoB.WHO_M_02157:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	992	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1071	92.0	1	SNP	p	V57M	1	.	.	169	171	ATG	518	520	ATG	216;217;216	A;T;G	205;206;206	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
